deltatrials

Schizophrenia Trials in Műnchen, Germany

Conditions / Schizophrenia / Műnchen, Germany

Schizophrenia is a medical condition with active clinical research programs worldwide.

38 total trials for this combination

Showing top 10 of 38 trials

Trials

NCT ID Title Status Phase
NCT01192906 A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309) COMPLETED PHASE3
NCT01714661 Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy COMPLETED PHASE3
NCT01050582 A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children COMPLETED PHASE4
NCT01515423 Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia COMPLETED PHASE3
NCT00396214 Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients TERMINATED PHASE3
NCT04860830 CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia COMPLETED PHASE3
NCT00460512 An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia COMPLETED PHASE3
NCT03187769 Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder COMPLETED PHASE3
NCT05211947 A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study TERMINATED PHASE3
NCT01235585 A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306) COMPLETED PHASE3

Related Pages